Clin2
NCT07143279Possibly a fitRecruiting

Testosterone for quality of life in men with advanced cancer

HypotestosteronismPalliative Care

Part of Hormones & metabolism clinical trials.

This trial tests if testosterone supplements can improve quality of life for men with low testosterone who are no longer receiving active cancer treatment. It aims to help with symptoms like fatigue and low mood.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a man with low testosterone (below 231 ng/dl).
  • You are receiving best supportive care and have no further cancer treatment options.
  • You are at least 18 years old.
  • You are able to understand and sign a consent form.
  • You do not have untreated prostate cancer.
  • You are not allergic to the study drug, peanuts, or soya.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04833426Recruiting· Phase 3
Testosterone levels around prostate surgery and recovery outcomes

This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.

Amsterdam
NCT04049331Recruiting· Phase 2
Testosterone therapy for cancer survivors with fatigue

This trial tests whether testosterone replacement can help male cancer survivors who have ongoing fatigue and low testosterone levels. It is for men who have completed chemotherapy or radiation and are cancer-free for at least a year.

Boston, Massachusetts
NCT07466498Not yet recruiting· Phase 2
Estrogen for quality of life in men with advanced prostate cancer

This study tests whether estrogen patches can improve quality of life for men with prostate cancer that has spread but still responds to hormones. It compares adding estrogen to standard hormone therapy alone.

Seattle, Washington
NCT06733350Recruiting· Phase 4
Testosterone therapy for low testosterone in men with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.

Buffalo, New York
NCT07028255Not yet recruiting
Testosterone supplement study for low energy in men

This trial tests whether a daily testosterone supplement can help men aged 28-65 who feel low energy, mood changes, or other symptoms linked to aging. It requires taking the supplement for several weeks and providing blood samples.

Carlsbad, California
NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for men with low-risk prostate cancer on active surveillance

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.

Miami, Florida

Hear when a new Palliative Care trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.